MicroRNA alteration, application as biomarkers, and therapeutic approaches in neurodegenerative diseases

TPN Nguyen, M Kumar, E Fedele, G Bonanno… - International journal of …, 2022 - mdpi.com
MicroRNAs (miRNAs) are essential post-transcriptional gene regulators involved in various
neuronal and non-neuronal cell functions and play a key role in pathological conditions …

MicroRNA networks in cognition and dementia

GS Blount, L Coursey, J Kocerha - Cells, 2022 - mdpi.com
The change from viewing noncoding RNA as “junk” in the genome to seeing it as a critical
epigenetic regulator in almost every human condition or disease has forced a paradigm shift …

FUS alters circRNA metabolism in human motor neurons carrying the ALS-linked P525L mutation

A Colantoni, D Capauto, V Alfano, E D'Ambra… - International Journal of …, 2023 - mdpi.com
Deregulation of RNA metabolism has emerged as one of the key events leading to the
degeneration of motor neurons (MNs) in Amyotrophic Lateral Sclerosis (ALS) disease …

RNA deregulation in amyotrophic lateral sclerosis: the noncoding perspective

P Laneve, P Tollis, E Caffarelli - International journal of molecular …, 2021 - mdpi.com
RNA metabolism is central to cellular physiopathology. Almost all the molecular pathways
underpinning biological processes are affected by the events governing the RNA life cycle …

Plasma NfL levels and longitudinal change rates in C9orf72 and GRN-associated diseases: from tailored references to clinical applications

D Saracino, K Dorgham, A Camuzat… - Journal of Neurology …, 2021 - jnnp.bmj.com
Objective Neurofilament light chain (NfL) is a promising biomarker in genetic frontotemporal
dementia (FTD) and amyotrophic lateral sclerosis (ALS). We evaluated plasma …

[HTML][HTML] Decreased miR-451a in cerebrospinal fluid, a marker for both cognitive impairment and depressive symptoms in Alzheimer's disease

H Feng, P Hu, Y Chen, H Sun, J Cai, X He, Q Cao… - Theranostics, 2023 - ncbi.nlm.nih.gov
Background: Alzheimer's disease (AD) patients are often accompanied by depressive
symptoms, but its underlying mechanism remains unclear. The present study aimed to …

[HTML][HTML] Biomarkers in frontotemporal dementia: Current landscape and future directions

A Gifford, N Praschan, A Newhouse… - Biomarkers in …, 2023 - Elsevier
Frontotemporal dementia (FTD) is one of the most common neurodegenerative diseases,
encompassing a myriad of different, clinically distinct subtypes which all target the …

Signature of miRNAs derived from the circulating exosomes of patients with amyotrophic lateral sclerosis

YF Cheng, XJ Gu, TM Yang, QQ Wei, B Cao… - Frontiers in Aging …, 2023 - frontiersin.org
Background Amyotrophic lateral sclerosis (ALS) is a progressive, fatal neurodegenerative
disorder (NDS) with unclear pathophysiology and few therapeutic options. Mutations in …

Shared miRNA landscapes of COVID-19 and neurodegeneration confirm neuroinflammation as an important overlapping feature

S Redenšek Trampuž, D Vogrinc, K Goričar… - Frontiers in molecular …, 2023 - frontiersin.org
Introduction Development and worsening of most common neurodegenerative diseases,
such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis, have been …

MicroRNA biomarkers in frontotemporal dementia and to distinguish from Alzheimer's disease and amyotrophic lateral sclerosis

B Martinez, PV Peplow - Neural Regeneration Research, 2022 - journals.lww.com
Frontotemporal lobar degeneration describes a group of progressive brain disorders that
primarily are associated with atrophy of the prefrontal and anterior temporal lobes …